253 related articles for article (PubMed ID: 35501999)
1. Evaluation of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Lessons learned from a 14-year retrospective study.
Tau J; Fernando LP; Munoz MC; Poh C; Krishnan VV; Dwyre DM
Ther Apher Dial; 2023 Feb; 27(1):136-145. PubMed ID: 35501999
[TBL] [Abstract][Full Text] [Related]
2. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
Martin SD; McGinnis E; Smith TW
Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
[TBL] [Abstract][Full Text] [Related]
3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
4. Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.
Liu A; Dhaliwal N; Upreti H; Kasmani J; Dane K; Moliterno A; Braunstein E; Brodsky R; Chaturvedi S
Transfusion; 2021 Jan; 61(1):266-273. PubMed ID: 33179792
[TBL] [Abstract][Full Text] [Related]
5. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
[TBL] [Abstract][Full Text] [Related]
6. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
Mancini I; Agosti P; Boscarino M; Ferrari B; Artoni A; Palla R; Spreafico M; Crovetti G; Volpato E; Rossini S; Novelli C; Gattillo S; Barcella L; Salmoiraghi M; Falanga A; Peyvandi F;
Orphanet J Rare Dis; 2022 Jun; 17(1):246. PubMed ID: 35739601
[TBL] [Abstract][Full Text] [Related]
7. The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry.
Hassan S; Westwood JP; Ellis D; Laing C; Mc Guckin S; Benjamin S; Scully M
Br J Haematol; 2015 Dec; 171(5):830-5. PubMed ID: 26359646
[TBL] [Abstract][Full Text] [Related]
8. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
Williams LA; Marques MB;
Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
[TBL] [Abstract][Full Text] [Related]
9. ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.
Bittar PG; Nickolich MS; Onwuemene OA
J Clin Apher; 2018 Jun; 33(3):423-426. PubMed ID: 28940604
[TBL] [Abstract][Full Text] [Related]
10. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
Li A; Khalighi PR; Wu Q; Garcia DA
J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619
[TBL] [Abstract][Full Text] [Related]
11. Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing.
Merlen C; Pépin E; Barry O; Cormier A; Dubois C; Lapeyraque AL; Troyanov S; Rivard GE; Bonnefoy A
Orphanet J Rare Dis; 2022 Aug; 17(1):308. PubMed ID: 35927768
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
Saha M; McDaniel JK; Zheng XL
J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
[TBL] [Abstract][Full Text] [Related]
13. Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: A 10-year provincial retrospective cohort study.
Sawler D; Parker A; Britto J; Goodyear MD; Sun HL
Thromb Res; 2020 Sep; 193():53-59. PubMed ID: 32521335
[TBL] [Abstract][Full Text] [Related]
14. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
[TBL] [Abstract][Full Text] [Related]
15. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
Scully M; Cataland S; Coppo P; de la Rubia J; Friedman KD; Kremer Hovinga J; Lämmle B; Matsumoto M; Pavenski K; Sadler E; Sarode R; Wu H;
J Thromb Haemost; 2017 Feb; 15(2):312-322. PubMed ID: 27868334
[TBL] [Abstract][Full Text] [Related]
16. Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report.
Mousseaux C; Joly BS; Mohamadou I; Arrestier R; Hertig A; Rafat C
BMC Nephrol; 2020 May; 21(1):204. PubMed ID: 32471388
[TBL] [Abstract][Full Text] [Related]
17. Utility of Different Scoring Systems for the Diagnosis of Thrombotic Microangiopathies.
Yilmaz S; Cenelİ O; Tekinalp A
J Coll Physicians Surg Pak; 2023 May; 33(5):539-543. PubMed ID: 37190689
[TBL] [Abstract][Full Text] [Related]
18. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
[TBL] [Abstract][Full Text] [Related]
19. Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea.
Park SH; Kim HK; Jeong J; Lee SH; Lee YJ; Kim YJ; Jo JC; Lim JH
Ann Lab Med; 2023 Sep; 43(5):485-492. PubMed ID: 37080750
[TBL] [Abstract][Full Text] [Related]
20. [Frontline clinical practice for thrombotic thrombocytopenic purpura].
Miyakawa Y
Rinsho Ketsueki; 2020; 61(9):1331-1337. PubMed ID: 33162533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
